Genome-edited Camelina Receives Positive Response from USDA APHIS, Field Trial ProceedsApril 29, 2020
To confirm the regulatory status of the genome-edited C3007 trait in camelina, its developer, Yield10 Bioscience submitted an "Am I regulated?" letter to the Biotechnology Regulatory Services (BRS) of the USDA Animal and Plant Health Inspection Service. BRS responded positively, indicating that the plant lines do not meet the definition of a regulated article under 7 CFR Part 340.
The genome-edited camelina lines have increased oil content to help increase the supply of omega fatty acid-containing oils for human nutrition and aquaculture markets. With the clarification of the regulatory status of the genome-edited camelina, the developers will proceed with the conduct of field trials in the 2020 growing season.
You might also like:
- GM Plants Promise Fish Oils Aplenty
- CRISPR-Cas9 Triple Gene Edited Camelina Plant Receives Nonregulated Status
- Defra Approves GM Camelina Field Trials
The Crop Biotech Update is a weekly newsletter of ISAAA, a non-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
- FAO, IFAD, World Bank, and WFP Joint Statement on COVID-19 Impacts on Food Security and Nutrition: Countries Must Work Together to Ensure Food for All
- Nanoengineers Combine Molecular Farming and Advanced Manufacturing to Develop COVID-19 Vaccine
News from Around the World
- Global Report Reveals Scope of Food Crises as COVID-19 Poses New Risks to Vulnerable Countries
- New Video: We are ISAAA
- Rice Genetically Engineered to Resist Extreme Heat also Produces Up to 20% More Grain
- 10-year Post-Market Evaluation in EU Reports No Adverse Effects by GM Maize MON810
- Zeaxanthin‐rich Tomato Fruit Developed Through Genetic Manipulations of Carotenoid Biosynthesis
- Brightest Engineered Plants Glow Throughout Life Cycle
Plant Breeding Innovations
- Genome-edited Camelina Receives Positive Response from USDA APHIS, Field Trial Proceeds
- Ag-economist Pushes for Regulatory Reforms, Renewed Public Debate on New Plant Breeding Techniques
Subscribe to CBU: